Open Access

Erratum to: Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trial

  • Kaitlin Siou1,
  • Sharon L. Walmsley2, 3,
  • Kellie E. Murphy4, 3,
  • Janet Raboud1,
  • Mona Loutfy5, 6, 3,
  • Mark H. Yudin7, 3,
  • Michael Silverman8, 9,
  • Noor N. Ladhani10, 3,
  • Eszter Papp1 and
  • Lena Serghides1, 3, 6Email author
Pilot and Feasibility Studies20173:21

https://doi.org/10.1186/s40814-017-0135-x

Published: 28 April 2017

The original article was published in Pilot and Feasibility Studies 2016 2:49

Erratum

After publication of the original article [1], it came to the authors’ attention that a significant contributor to the protocol, Dr Eszter Papp, had not been included as a co-author.

Dr. Papp contributed to the conception, design, and initial draft of the study protocol, so the Author contributions section of the article should be revised as follows:

Author contributions

All authors contributed to the development of the trial protocol and approved the final manuscript. KS led the development of the operations manual and standardization of data collection, undertook initial drafting of the manuscript, and is involved in the overall coordination of the multi-site study. LS, SW, and KM conceived the study, obtained funding, drafted the initial protocol, and are responsible for the communication of the study results. Guidance on clinical data, participant examinations, and study procedures were provided by SW, KM, ML, and MY. JR contributed to the design of this pilot study. SW, KM, ML, MY, NL, and MS led the study at the site responsible for patient recruitment, follow-up, and clinical evaluation. EP contributed to the conception, design, and initial draft of the study protocol.

Dr. Papp has no conflicts of interest to declare.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Toronto General Research Institute
(2)
Toronto General Hospital
(3)
University of Toronto
(4)
Mount Sinai Hospital
(5)
Maple Leaf Medical Clinic
(6)
Women’s College Research Institute
(7)
St. Michael’s Hospital
(8)
St. Joseph’s Health Care London
(9)
University of Western Ontario
(10)
Sunnybrook Health Sciences Centre

Reference

  1. Siou K, Walmsley SL, Murphy KE, Raboud J, Loutfy M, Yudin MH, et al. Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trial. Pilot Feasibility Stud. 2016;2:49. doi:https://doi.org/10.1186/s40814-016-0087-6.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement